According to the number of CD33+ MDSCs that infiltrated locally, breast cancer patients were divided into lowly infiltrated MDSC group (MDSCslow) and highly infiltrated MDSC group (MDSCshigh). The gene discussed is CD33; the disease is breast cancer.